11 reports

The report focuses on drugs and therapies being evaluated for Acute Asthma treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Asthma
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development

The report focuses on drugs and therapies being evaluated for Chronic Asthma treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Asthma
  • Chronic Disease
  • Clinical Trial
  • Drug Discovery And Development
  • VR647 - A Phase I Clinical Study of VR-647 in Adult Asthma Subjects
  • OCT 04, 2017: MUNDIPHARMA ANNOUNCES THE POSITIVE OUTCOME OF THE EUROPEAN DECENTRALISED PROCEDURE FOR FLUTIFORM K-HALER, A NOVEL TREATMENT FOR ADOLESCENTS AND ADULTS WITH ASTHMA

Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform.It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary...

  • Asthma
  • Europe
  • World
  • Company Financials
  • Vectura Group plc
  • Other Significant Developments Feb 28, 2017: Respiri's Text and App Messaging for Better Asthma Care
  • Deal Sub Type

Summary Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company’s proprietary applications,...

  • Asthma
  • Australia
  • United States
  • World
  • Company
  • 01/10/2018: ASTRAZENECA RECEIVES EU APPROVAL OF FASENRA FOR SEVERE EOSINOPHILIC ASTHMA
  • 11/14/2017: FASENRA (BENRALIZUMAB) RECEIVES US FDA APPROVAL FOR SEVERE EOSINOPHILIC ASTHMA

Summary Kyowa Hakko Kirin Co Ltd (Kyowa Hakko), a subsidiary of Kirin Holdings Company Limited, is a research and development (R&D) based biotechnology company.It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the...

  • Asthma
  • Japan
  • United States
  • Company
  • Kyowa Hakko Kirin Co., Ltd.
  • who participated in a previous dupilumab asthma clinical study. The trial is registered with the EU Clinical Trials Register.
  • RG-6149 - DRUG PROFILE

Nasal Polyps - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H1 2018, provides an overview of the Nasal Polyps (Ear Nose Throat Disorders) pipeline landscape. Nasal polyps (Nasal polyposis)...

  • Asthma
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • Jan 24, 2017: FDA approves IND to support Vectura's wholly-owned programme VR647 in paediatric asthma
  • Deal Type

Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform.It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary...

  • Asthma
  • United Kingdom
  • United States
  • Company Financials
  • Vectura Group plc
  • Nov 29, 2017: Circassia Welcomes New NICE Guidelines Recommending Use of FeNO Testing in Asthma Diagnosis

Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma.The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease. The company had...

  • Asthma
  • United States
  • Company
  • Demand
  • Circassia Pharmaceuticals plc
  • Allergic Asthma
  • SMALL MOLECULES TO ANTAGONIZE PTGDR2 FOR ASTHMA - DRUG PROFILE

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2018 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein...

  • Asthma
  • Hospital
  • United States
  • World
  • Product Initiative
  • ASTRAZENECA ENTERS INTO LICENSING AGREEMENT WITH SYNAIRGEN FOR SNG001
  • PARTNERSHIPS

It targets interferon alpha receptor ## and ##.

  • Asthma
  • Pharmaceutical
  • United Kingdom
  • United States
  • Synairgen plc
  • SKP-2075 - PRODUCT DESCRIPTION
  • RPL554 - DRY POWDER INHALER - PRODUCT DESCRIPTION

Inhalers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Inhalers - Medical Devices Pipeline Assessment, 2018" provides an overview of Inhalers currently in pipeline stage. The report provides comprehensive information on the pipeline products...

  • Asthma
  • Respiratory Disease
  • United States
  • Company Financials
  • Orion Corporation